Abstract
In distal colon, both nitric oxide (NO) and ATP are involved in non-adrenergic non-cholinergic (NANC) inhibitory neurotransmission. The role of the soluble guanylate cyclase (sGC) isoforms alpha(1)beta(1) and alpha(2)beta(1), and of the small conductance Ca(2+)-dependent K(+) channels (SK(Ca) channels) in the relaxation of distal colon by exogenous NO and by NANC nerve stimulation was investigated, comparing wild type (WT) and sGCalpha(1) knockout (KO) mice. In WT strips, the relaxation induced by electrical field stimulation (EFS) at 1 Hz but not at 2-8 Hz was significantly reduced by the NO-synthase inhibitor L-NAME or the sGC inhibitor ODQ. In sGCalpha(1) KO strips, the EFS-induced relaxation at 1 Hz was significantly reduced and no longer influenced by L-NAME or ODQ. The SK(Ca) channel blocker apamin alone had no inhibitory effect on EFS-induced relaxation, but combined with ODQ or L-NAME, apamin inhibited the relaxation induced by EFS at 2-8 Hz in WT strips and at 8 Hz in sGCalpha(1) KO strips. Relaxation by exogenous NO was significantly attenuated in sGCalpha(1) KO strips, but could still be reduced further by ODQ. Basal cGMP levels were lower in sGCalpha(1) KO strips but NO still significantly increased cGMP levels versus basal. In conclusion, in the absence of sGCalpha(1)beta(1), exogenous NO is able to partially act through sGCalpha(2)beta(1). NO, acting via sGCalpha(1)beta(1), is the principal neurotransmitter in EFS-evoked responses at 1 Hz. At higher stimulation frequencies, NO, acting at sGCalpha(1)beta(1) and/or sGCalpha(2)beta(1), functions together with another transmitter, probably ATP acting via SK(Ca) channels, with some degree of redundancy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apamin / pharmacology
-
Blotting, Western
-
Colon / drug effects
-
Colon / enzymology
-
Colon / innervation*
-
Cyclic GMP / analogs & derivatives
-
Cyclic GMP / metabolism
-
Cyclic GMP / pharmacology
-
Dose-Response Relationship, Drug
-
Electric Stimulation
-
Enzyme Inhibitors / pharmacology
-
Female
-
Gastrointestinal Motility* / drug effects
-
Guanylate Cyclase / antagonists & inhibitors
-
Guanylate Cyclase / deficiency
-
Guanylate Cyclase / genetics
-
Guanylate Cyclase / metabolism*
-
Male
-
Mice
-
Mice, Knockout
-
Muscle Relaxation* / drug effects
-
Muscle, Smooth / drug effects
-
Muscle, Smooth / enzymology
-
Muscle, Smooth / innervation*
-
Myenteric Plexus / drug effects
-
Myenteric Plexus / enzymology
-
Myenteric Plexus / metabolism*
-
NG-Nitroarginine Methyl Ester / pharmacology
-
Neural Inhibition
-
Nitric Oxide / metabolism*
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Nitric Oxide Synthase / metabolism
-
Oxadiazoles / pharmacology
-
Potassium Channel Blockers / pharmacology
-
Protein Subunits
-
Quinoxalines / pharmacology
-
Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors
-
Receptors, Cytoplasmic and Nuclear / deficiency
-
Receptors, Cytoplasmic and Nuclear / genetics
-
Receptors, Cytoplasmic and Nuclear / metabolism*
-
Small-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors
-
Small-Conductance Calcium-Activated Potassium Channels / metabolism*
-
Soluble Guanylyl Cyclase
-
Vasoactive Intestinal Peptide / metabolism
Substances
-
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
-
Enzyme Inhibitors
-
Gucy1a2 protein, mouse
-
Oxadiazoles
-
Potassium Channel Blockers
-
Protein Subunits
-
Quinoxalines
-
Receptors, Cytoplasmic and Nuclear
-
Small-Conductance Calcium-Activated Potassium Channels
-
Apamin
-
8-bromocyclic GMP
-
Nitric Oxide
-
Vasoactive Intestinal Peptide
-
Nitric Oxide Synthase
-
Guanylate Cyclase
-
Soluble Guanylyl Cyclase
-
Cyclic GMP
-
NG-Nitroarginine Methyl Ester